Abstract

Thyroid Potency Calculations

Author(s): Stack Bob

Issue: Jul/Aug 2010 - Sterile Compounding

Page(s): 306-309

Download in electronic PDF format for $75

Abstract

The United States Pharmacopeia defines the label strength for Levothyroxine Sodium USP, Liothyronine Sodium USP, and Thyroid Powder USP. These powders need a certificate of analysis for potency calculations. This article is an explanation of the calculations involved to achieve the correct United States Pharmacopeia label strength for thyroid hormones.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2010 Pg. 306-309	Thyroid Potency Calculations Author(s): Stack Bob
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2012 Pg. 376-380	Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Author(s): Snyder Scott, Listecki Robert E
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Nov/Dec 2008 Pg. 545	Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 547	Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 548	Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 268-273	Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Author(s): Milner Martin
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 226-229	Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis? Author(s): Zolner William J
Nov/Dec 2013 Pg. 505	Levothyroxine Sodium 100-mcg Capsules Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 247	Levothyroxine Sodium 40-micro-g/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 414-419	Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
May/Jun 2010 Pg. 193-199	The Role of Sex Hormones on Fibromyalgia Pain Mediators Author(s): Bramwell Bethany L
Jan/Feb 2011 Pg. 56-61	Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 488-497	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Jan/Feb 2024 Pg. 34-43	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Jan/Feb 2008 Pg. 50-53	Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method Author(s): Kupiec Thomas C, Skinner Rodney, Lanier Lance